PJP (Invesco Pharmaceuticals ETF) Stock Analysis - Hedge Fund Holdings

Invesco Pharmaceuticals ETF (PJP) is a publicly traded the market company. As of May 21, 2026, PJP trades at $104.76 with a market cap of $0 and a P/E ratio of 0.00. PJP moved -0.22% today. Year to date, PJP is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces PJP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns PJP stock?

Hedge funds tracked by Rallies that own PJP include Citadel Advisors. The latest tracked quarter is Sep 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Invesco Pharmaceuticals ETF.

PJP Key Metrics

Key financial metrics for PJP
MetricValue
Price$104.76
Market Cap$0
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$0.00
52-Week Low$0.00
Volume282.19K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Top Hedge Funds Holding PJP

  • Citadel Advisors holds 13.71K shares of PJP, changed +91.63% as of Sep 30, 2024.

PJP Analyst Consensus

PJP analyst coverage data. Average price target: $0.00.

Common questions about PJP

Who owns PJP stock?
Hedge funds tracked by Rallies that own PJP include Citadel Advisors. The latest tracked quarter is Sep 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Invesco Pharmaceuticals ETF.
Does Rallies show 13F holders for PJP?
Yes. Rallies tracks hedge fund and 13F ownership data for PJP, including fund names, share counts, latest tracked quarter, and position changes when available.
Is PJP research on Rallies investment advice?
No. Rallies provides research, data, and educational context for PJP. It does not provide personalized investment advice.
PJP

PJP